Artificial Intelligence
Fujifilm Launches FUJIFILM X-S20 Mirrorless Digital Camera
<!– Name:DistributionId Value:8845347 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value: –> <!– Name:CustomerId Value:1221470 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:37b92dce-4bdf-4859-aaaf-be83bbb883a1 –>
VALHALLA, N.Y., May 24, 2023 (GLOBE NEWSWIRE) — FUJIFILM North America Corporation announced today the launch of its FUJIFILM X-S20 mirrorless digital camera (X-S20). With a lightweight, compact form factor reminiscent of its predecessor, the FUJIFILM X-S10, X-S20 brings new features including AI-based subject-detection autofocus (AF), the capability to record 6.2K/30P video, and stream 4K/60P video natively through USB-C.
“X-S20 is truly a dream camera for any content creator looking to take their photos and videos creation to the next level, but especially for the ones that are documenting their lives, traveling the world, or streaming their stories online,” said Lisa Baxt, marketing director, Electronic Imaging Division, FUJIFILM North America Corporation. “It offers premium image quality and advanced portability, catering to a variety of image creation styles ranging from casual self-portraits to full-fledged photography and videography. With content creators turning to digital cameras more than ever before, we are confident that X-S20 will be well received by users pushing long-form content to platforms, like Twitch, especially since no fees are required to unlock the feature.”
Main features:
High image quality and high-performance AF
- X-S20 is equipped with the back-illuminated 26.1MP sensor “X-Trans™ CMOS 4” and the high-speed image processing engine “X-Processor 5” to produce high-quality images while keeping power consumption lower than its predecessor model, X-S10.
- X-S20 features subject-detection AF developed with deep learning/artificial intelligence (AI) technology. In this case, AI is used to detect animals, birds, cars, motorcycles, bicycles, airplanes, trains, insects, and drones. The evolved AF prediction algorithm enables stable focusing even in AF-C mode.
- The AUTO mode, which automatically selects optimum settings according to scenes, is complemented with the new AUTO Subject Detection function, automatically detecting and tracking a subject while keeping it in focus, allowing the creator to produce high-quality stills and videos with ease.
- X-S20 comes with 19 Film Simulation modes including “Nostalgic Neg,” characterized by high saturation and soft tonality. Users can use Film Simulation presets for various subject types and scenes to produce a photographic film look and feel.
High-capacity battery and high-performance in-body image stabilization (IBIS) mechanism in a lightweight form factor
- X-S20 features the X-S Series’ signature large grip for reliable handheld stability while keeping the body compact and lightweight, weighing in at just 1.08 lbs. (491g).[1]
- The use of the high-capacity battery, NP-W235, has more than doubled the number of frames in Economy Mode to approximately 800 compared to that of the previous X-S10 model.
- X-S20 is equipped with a five-axis IBIS mechanism that offers up to 7.0-stops[2], making it easy to create images or video hand-held, even at night or in low-light conditions.
- X-S20 features a 2.36-million-dot Electronic Viewfinder (EVF) with 0.62x magnification as well as a 1.84-million-dot rear LCD monitor with a vari-angle structure that can be positioned in a range of angles, making self-portraits easy. The camera can be also combined with the FUJIFILM Tripod Grip, TG-BT1, for vlog production.
6.2K/30P video recording and other extensive video functions including the new Vlog Mode
- X-S20 can record 6.2K/30P 4:2:2 10-bit video internally and supports extensive video functions that include capabilities, like hi-speed 1080/240P slow motion and 4K/60P streaming through USB-C.
- X-S20 features F-Log2 for recording video in the expanded 13+ stops dynamic range for enriched tonality, adding freedom in post-production creativity.
- When combined with an ATOMOS HDMI device, RAW video output from the X-S20 can be recorded as 12-bit Apple ProRes RAW at resolutions up to 6.2K and frame rates up to 29.97fps. When combined with Blackmagic Design Video Assist 12G, RAW video output from X-S20 can be recorded as Blackmagic RAW at resolutions up to 6.2K and frame rates up to 29.97fps.
- X-S20 features a 3.5mm microphone/headphone jack for broad compatibility with today’s available audio tools, despite its compact and lightweight body. Furthermore, the new Vlog Mode has been introduced to facilitate Vlog production.
- A USB-Type C cable can connect the camera to a computer to use as a webcam without the need for additional software[3]. Alternatively, content creators can utilize OBS Studio with X-S20 to stream 4K/60P video directly from the camera to the online streaming platform of their choice. Film Simulation modes are available even during live streaming or online meetings. Image settings can be adjusted even while the camera is connected to a computer.
Pricing and Availability:
FUJIFILM X-S20 mirrorless digital camera body and camera body with lens kits will be available from authorized FUJIFILM dealers in the United States on or around June 29th, 2023.
FUJIFILM X-S20 Mirrorless Camera Body in Black will be available at a manufacturer’s suggested retail price of $1,299.95 USD and $1,749.99 CAD.
FUJIFILM X-S20 Mirrorless Camera Body in Black with the FUJINON XC15-45mmF3.5-5.6 OIS PZ Lens Kit will be available at a manufacturer’s suggested retail price of $1,399.95 USD and $1,899.99 CAD.
FUJIFILM X-S20 Mirrorless Camera Body in Black with the FUJINON XF18-55mmF2.8-4 R LM OIS Lens Kit will be available at a manufacturer’s suggested retail price of $1,699.95 and $2,299.99 CAD.
For more information, visit https://fujifilm-x.com/en-us/products/cameras/x-s20/.
About Fujifilm
FUJIFILM North America Corporation, a marketing subsidiary of FUJIFILM Holdings America Corporation, consists of five operating divisions and one subsidiary company. The Imaging Division provides consumer and commercial photographic products and services, including: photographic paper; digital printing equipment, along with service and support; personalized photo products; film; one-time-use cameras; and the popular INSTAX® line of instant cameras and accessories. The Electronic Imaging Division markets consumer digital cameras, lenses, and content creation solutions, and the Graphic Communication Division supplies products and services to the graphic printing industry. The Optical Devices Division provides optical lenses for broadcast, cinematography, closed circuit television, videography, and industrial markets, and also markets binoculars and other optical imaging solutions. The Industrial and Corporate New Business Development Division delivers new products derived from Fujifilm technologies. FUJIFILM Canada Inc. sells and markets a range of FUJIFILM products and services in Canada.
For more information, please visit https://www.fujifilm.com/us/en/about/region, go to https://www.twitter.com/fujifilmus to follow Fujifilm on Twitter, or go to http://www.facebook.com/FujifilmNorthAmerica to Like Fujifilm on Facebook.
FUJIFILM Holdings Corporation, Tokyo, leverages its depth of knowledge and proprietary core technologies to deliver “Value from Innovation” in our products and services in the business segments of healthcare, materials, business innovation, and imaging. Our relentless pursuit of innovation is focused on providing social value and enhancing the lives of people worldwide. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship. For more information about Fujifilm’s Sustainable Value Plan 2030, click here. For the year ended March 31, 2023, the company had global revenues of approximately 2.9 trillion yen (21 billion USD at an exchange rate of 134 yen/dollar). For more information, please visit: www.fujifilmholdings.com.
FUJIFILM and FUJINON are trademarks of FUJIFILM Corporation and its affiliates. Apple Pro Res is a trademark of its respective third-party owner.
©2023 FUJIFILM North America Corporation and its affiliates. All rights reserved.
[1] Referenced weight includes supplied battery and memory card.
[2] With FUJINON XF35mmF1.4R lens mounted.
[3] 4K output requires a 4K compatible monitor, a USB cable of USB 3.0 or greater, and supported software
Artificial Intelligence
Clinical Trials Matching Software Market Projected to Reach $832.56 million by 2030 – Exclusive Report by 360iResearch
PUNE, India, April 18, 2024 /PRNewswire/ — The report titled “Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use – Global Forecast 2024-2030” is now available on 360iResearch.com’s offering, presents an analysis indicating that the market projected to grow from a size of $342.20 million in 2023 to reach $832.56 million by 2030, at a CAGR of 13.54% over the forecast period.
“The Global Surge in Adoption of Matching Software for Enhanced Participant Enrollment”
Clinical trials matching software stands at the forefront of revolutionizing clinical research by automating the process of identifying and enrolling eligible participants. These platforms offer a streamlined approach to match patient health profiles with trial requirements, accelerating enrollment and supporting the shift toward personalized healthcare using these advanced AI and ML technologies. Although integrating these systems poses challenges due to variations in healthcare IT infrastructure and the imperative for rigorous data security, the potential for market growth is substantial. In the Americas, a robust clinical trials ecosystem thrives; in the European Union, it has unified regulatory standards and extended to emerging regions such as the Middle East, Africa, and the APAC countries; the demand for such innovative solutions is on a steep rise. This demand is fueled by governmental support, the evolving regulatory landscape, and strategic partnerships to embed these solutions within electronic health records, underscoring a global movement toward optimizing clinical trial processes to better cater to specific patient demographics.
Download Sample Report @ https://www.360iresearch.com/library/intelligence/clinical-trials-matching-software
“The Rise of Virtual Trials and Advanced Matching Software”
The healthcare landscape is witnessing a transformative shift toward virtual clinical trials, fueled by technological advancements and the necessity for continuity during the COVID-19 pandemic. This transition supports research amid social distancing measures and introduces significant cost savings by reducing the need for physical infrastructure and in-person interactions. The efficiencies brought by electronic health records (EHR), wearable technologies, and automation streamline the entire process, from patient recruitment to data analysis. Several approaches, endorsed by regulatory bodies such as the FDA, represent a leap forward in making clinical trials more accessible and streamlined, ensuring that more patients can participate in potentially life-saving research without the geographical and logistic constraints of traditional trials.
“Enhancing Clinical Trials through Advanced Analytics, Rigorous Compliance, and Precision-Patient Matching”
Integrating advanced analytics, meticulous compliance monitoring, and precision-patient matching marks a significant advancement toward maximizing efficiency and fostering trial diversity. The software delivers insightful data on trial progress, participant demographics, and enrollment figures, empowering stakeholders to make well-informed decisions and optimize resource distribution to meet trial goals effectively by implementing cutting-edge analytics. The built-in compliance feature ensures trials are conducted in strict adherence to regulatory standards, minimizing risks associated with non-compliance. Furthermore, a robust data management system guarantees the integrity and availability of clinical trial data, which is critical for the seamless operation and real-time analysis of trials. The software includes state-of-the-art patient matching technology, which employs sophisticated algorithms and artificial intelligence to expedite recruitment by accurately identifying candidates who match specific trial requirements. This innovative approach accelerates the recruitment timeline and enhances the diversification of trial participants, paving the way for more inclusive and representative clinical research outcomes.
Request Analyst Support @ https://www.360iresearch.com/library/intelligence/clinical-trials-matching-software
“Medidata by Dassault Systèmes SE at the Forefront of Clinical Trials Matching Software Market with a Strong 11.30% Market Share”
The key players in the Clinical Trials Matching Software Market include International Business Machines Corporation, Science 37, Inc. by eMed, LLC, Medidata by Dassault Systèmes SE, AutoCruitment LLC, Deep 6 AI Inc., and others. These prominent players focus on strategies such as expansions, acquisitions, joint ventures, and developing new products to strengthen their market positions.
“Introducing ThinkMi: Revolutionizing Market Intelligence with AI-Powered Insights for the Clinical Trials Matching Software Market”
We proudly unveil ThinkMi, a cutting-edge AI product designed to transform how businesses interact with the Clinical Trials Matching Software Market. ThinkMi stands out as your premier market intelligence partner, delivering unparalleled insights with the power of artificial intelligence. Whether deciphering market trends or offering actionable intelligence, ThinkMi is engineered to provide precise, relevant answers to your most critical business questions. This revolutionary tool is more than just an information source; it’s a strategic asset that empowers your decision-making with up-to-the-minute data, ensuring you stay ahead in the fiercely competitive Clinical Trials Matching Software Market. Embrace the future of market analysis with ThinkMi, where informed decisions lead to remarkable growth.
Ask Question to ThinkMi @ https://app.360iresearch.com/library/intelligence/clinical-trials-matching-software
“Dive into the Clinical Trials Matching Software Market Landscape: Explore 190 Pages of Insights, 286 Tables, and 22 Figures”
PrefaceResearch MethodologyExecutive SummaryMarket OverviewMarket InsightsClinical Trials Matching Software Market, by FunctionalityClinical Trials Matching Software Market, by DeploymentClinical Trials Matching Software Market, by End-UseAmericas Clinical Trials Matching Software MarketAsia-Pacific Clinical Trials Matching Software MarketEurope, Middle East & Africa Clinical Trials Matching Software MarketCompetitive LandscapeCompetitive PortfolioInquire Before Buying @ https://www.360iresearch.com/library/intelligence/clinical-trials-matching-software
Related Reports:
Clinical Trial Support Services Market – Global Forecast 2024-2030Virtual Clinical Trials Market – Global Forecast 2024-2030Clinical Trials Management System Market – Global Forecast 2024-2030About 360iResearch
Founded in 2017, 360iResearch is a market research and business consulting company headquartered in India, with clients and focus markets spanning the globe.
We are a dynamic, nimble company that believes in carving ambitious, purposeful goals and achieving them with the backing of our greatest asset — our people.
Quick on our feet, we have our ear to the ground when it comes to market intelligence and volatility. Our market intelligence is diligent, real-time and tailored to your needs, and arms you with all the insight that empowers strategic decision-making.
Our clientele encompasses about 80% of the Fortune Global 500, and leading consulting and research companies and academic institutions that rely on our expertise in compiling data in niche markets. Our meta-insights are intelligent, impactful and infinite, and translate into actionable data that support your quest for enhanced profitability, tapping into niche markets, and exploring new revenue opportunities.
Contact 360iResearchMr. Ketan Rohom360iResearch Private Limited,Office No. 519, Nyati Empress,Opposite Phoenix Market City,Vimannagar, Pune, Maharashtra,India – 411014.Email: [email protected]: +1-530-264-8485India: +91-922-607-7550
To learn more, visit 360iresearch.com or follow us on LinkedIn, Twitter, and Facebook.
Logo – https://mma.prnewswire.com/media/2359256/360iResearch_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/clinical-trials-matching-software-market-projected-to-reach-832-56-million-by-2030—exclusive-report-by-360iresearch-302119709.html
BOSTON, April 18, 2024 /PRNewswire/ — The RepTrak™ Company, the world’s leading reputation data and insights company, released its annual Global RepTrak 100 report. Utilizing its advanced reputation monitoring software, RepTrak gathered data from more than 243,000 survey responses across 14 major economies to rank the world’s 100 most reputable companies. They share that ranking alongside a full analysis of global corporate reputation trends and corresponding public sentiment in the 2024 report.
After two years of consecutive Reputation Score declines, this year’s Score is back up with an increase from 73.2 in 2023 to 73.8 in 2024. It’s a small increase after 2023’s full one-point drop. However, it’s an encouraging sign that companies have begun to recover from reputation falls driven by many challenges: macroeconomic issues, workplace difficulties, product problems, and corporate responsibility skepticism.
“This year’s report underscores a pivotal shift in the corporate landscape, spotlighting the remarkable adaptability and dedication of the Top 100 companies in responding to the dynamic needs of stakeholders,” states RepTrak CEO Mark Sonders. “The companies featured in our report are not just riding the wave of change; they are the ones steering it, proving that the best approach to business is one that embraces evolution and champions progress.”
RepTrak’s report explores how people thought, felt, and acted toward companies over the past year. Findings include notable increases in Conduct and Citizenship efforts, stakeholders’ rising willingness to invest, culturally resonant brand communications, and ESG Scores that soared despite skepticism around the acronym.
To read the full 2024 Global RepTrak 100 report, please visit: www.reptrak.com/globalreptrak
About RepTrak
The RepTrak™ Company is the world’s leading reputation data and insights company. We help companies by organizing and grading a variety of reputational elements, offering a real-world report card on their corporate reputation. Subscribers to the RepTrak program use our predictive insights to protect business value, improve return on investment, and increase their positive impact on society. RepTrak’s pairing of advanced metrics and dedicated reputation advisors offers clients an actionable analysis of their reputation data, aligning business objectives with stakeholder sentiment across different markets and sectors.
Established in 2004, The RepTrak Company owns the world’s largest reputation benchmarking database, gathering over 1 million company ratings per year used by CEOs, boards, and executives in more than 60 countries worldwide. For more information, please visit: www.reptrak.com
Logo – https://mma.prnewswire.com/media/2391550/RepTrak_Logo_Logo.jpg
Photo – https://mma.prnewswire.com/media/2391551/2024_GRT_Spreads__Instagram_Post.jpg
View original content:https://www.prnewswire.co.uk/news-releases/reptrak-announces-2024-global-reptrak-100-report-302121513.html
Artificial Intelligence
Group-IB takes part in a global operation to cripple Canadian Phishing-as-a-Service provider LabHost
SINGAPORE, April 18, 2024 /PRNewswire/ — Group-IB, a leading cybersecurity company aimed at investigating, preventing, and fight digital crime announced today that it participated in a coordinated global takedown operation against prominent Canadian Phishing-as-a-Service (PhaaS) provider LabHost, which has led to the arrest of 37 suspects across the United Kingdom and around the world by law enforcement agencies. As part of the operation, Group-IB also conducted an extensive analysis of LabHost’s criminal history and infrastructure, including insights into LabHost’s administrative platform and the services it provides to its purported user base which exceeds 2,000 subscribers worldwide, who illegally obtained around 480,000 card numbers, 64,000 pin numbers, and over 1 million passwords from victims used for websites and other online services, according to law enforcement agencies.
“By leveraging our Threat Intelligence and Digital Risk Protection, we are able to identify and monitor phishing attacks and websites like those deployed by LabHost and its subscribers around the world, enabling us to actively alert and protect our customers, and in turn, their customers as well,” said Dmitry Volkov, Chief Executive Officer of Group-IB. “Today’s takedown operation demonstrates the agility and responsiveness of our decentralized Digital Crime Resistance Centers, and how quickly we can provide immediate and local assistance wherever our customers may be.”
First uncovered in late 2021, LabHost emerged as a fully automated Phishing-as-a-Service (PhaaS) platform, streamlining the creation of phishing websites meticulously mirroring the interface and functionality of prominent banking, postal, and financial entities, aimed at intercepting, seizing, and profiting from users’ personal, credit card, and online banking credentials. Users are prompted to select from various “membership plans,” tailored to target businesses and individuals in either the United States and Canada, or globally, akin to mobile subscription models. These plans encompass “standard,” “premium,” and “world membership” tiers, priced between US$179 and US$300 monthly, with options for monthly, quarterly, or annual billing cycles.
For media inquiries, please contact [email protected]
Photo – https://mma.prnewswire.com/media/2391017/Group_IB.jpgPhoto – https://mma.prnewswire.com/media/2391018/Group_IB_2.jpgLogo – https://mma.prnewswire.com/media/1853638/4657466/Group_IB_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/group-ib-takes-part-in-a-global-operation-to-cripple-canadian-phishing-as-a-service-provider-labhost-302121388.html
-
Uncategorized7 days agoArm CEO Rene Haas will be delivering a Partner’s Event Speech at COMPUTEX 2024
-
Artificial Intelligence7 days agoIn-Depth Analysis of Germany and France Data Center Markets: Germany Poised to Contribute Over $12.24 Billion Opportunities in the Next 6 Years – Arizton
-
Uncategorized7 days ago
BJEI: A New Record of High Performance in 2023 and a New Pattern of Diversified and Coordinated Development
-
Uncategorized7 days ago
Integrity Food Marketing Joins Forces with CA Ferolie to Expand East Coast Reach from Maine to Florida
-
Uncategorized7 days ago
Dimethyl Carbonate Market worth $1.9 billion by 2028 – Exclusive Report by MarketsandMarkets™
-
Artificial Intelligence7 days agoCogX Festival Set to Debut in Los Angeles at Century Plaza on May 7th, 2024
-
Artificial Intelligence7 days ago
aelf Leads the Fusion of AI and Blockchain to Shape the Future of Technology
-
Artificial Intelligence7 days agoXinhua Silk Road: Zoomlion Access pursues high-quality development with aerial work machinery sector innovation
